AbulKalam M. Shamsuddin, MD, PhD, had been a Professor of Pathology for over 40 years at the University of Maryland School of Medicine in Baltimore MD, USA.
Prof. Shamsuddin obtained a PhD degree in cancer research from UM. He joined the UM faculty in 1977; where he received the Best Teacher of the year award many times. He was also awarded the American Medical Students Association’s Golden Apple Award in 1999, which is given to only one medical professor each year in the US.
Besides various pathologies, Prof. Shamsuddin’s main focus has been the study of cancer formation and cancer prevention. His research on early stages of carcinogenesis has resulted in the development of this simple test for mass screening of cancers and precancers of the colon, lungs, breast etc.
Prof. Shamsuddin is also the pioneering scientist to demonstrate the anticancer and immune modulating action of the B-vitamin inositol and inositol hexaphosphate (IP6; www.ip-6.net). He holds several patents on the screening test and IP6, has published numerous scientific papers, book-chapters and books; and has been a sought-after speaker throughout the world.
Professor Shamsuddin's favorite uncle was a smoker and died of lung cancer. His dad also died of lung cancer, however he was not a smoker. Right from the start of his career, he was determined to find a way to detect cancer at the earliest stage- when there was still a good chance to beat it!
Dr. Vanderlinden has degrees in Business Administration, Naturopathic Medicine, and Chinese Medicine. He introduced several of the most useful natural health products into Canada. He is the founder of www.HopeScience.com a company that provides a leading science-based pain cream and joint health product called Active Again.
Dr. Vanderlinden entered natural medicine after seeing his mother overcome a terminal Hodgkin's lymphoma diagnosis with natural therapeutics when he was a teenager. Then several years later and only months after graduating as a Naturopathic Physician, his mother died of lung cancer. It is said that loss can lead to purpose, which it truly did for him, and ultimately to the formation of Early Detection, Inc.
He feels truly humbled to be able to contribute to making this screening test available to physicians and their patients. If one judges simply based on the number of lives that this technology will save, Dr. Vanderlinden feels that these tests represent one of the biggest medical advancements in decades.
Dr. Vanderlinden expects that these tests will become an essential component of annual exams. Yearly exams attempt to find disorders early so that they can be prevented and/or treated more effectively. For example, blood pressure and cholesterol are measured in order to more successfully manage cardiovascular risk of heart attacks and strokes.
He believes that a lack of a screening test for early cancer detection is the single greatest void in healthcare today. In time he expects annual physical exams without these screening tests will be considered undeniably incomplete.
Dr. Vanderlinden's mother died of lung cancer in her 50s, his only aunt died of breast cancer in her early 40s and his only cousin also died of breast cancer in her late 30s. If this test would have only been available at the time, his family would not have been so severely ravaged by cancer.
Gary J. McAdam is the Founder and President of Growth Ventures Inc., 1986-present.
Mr. McAdam is skilled in corporate structuring, business, strategic, and financial planning, capital formation, structuring and implementing merger and acquisition transactions. He is adept in assembling human resources including board members, management members, employees, business consultants, and advisors including investor relations, public relations, legal, accounting, auditing, and transfer agent services.
He has helped numerous companies with their corporate structure, and positioned them for financings and in arranging for and assisting management with appropriate individual and corporate investors and investment bankers.
Mr. McAdam has extensive experience transitioning companies from the private sector into the public sector through the merger process or via an IPO.
As Founder and President of Growth Ventures, Inc. (GVI), Mr. McAdam has conducted significant business consulting, strategic and capital advising, and merger and acquisition transactions. Have founded numerous companies and consulted with and participated in over 50 merger and acquisition transactions with private and public companies in a variety of industries. GVI and its Founder have been involved from inception or early stage with companies that have progressed to attract over $1 billion in equity financings.